BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16394785)

  • 1. Surfactant therapy in adults with acute lung injury/acute respiratory distress syndrome.
    Kesecioglu J; Haitsma JJ
    Curr Opin Crit Care; 2006 Feb; 12(1):55-60. PubMed ID: 16394785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant therapy for acute lung injury/acute respiratory distress syndrome.
    Haitsma JJ; Papadakos PJ; Lachmann B
    Curr Opin Crit Care; 2004 Feb; 10(1):18-22. PubMed ID: 15166845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
    Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.
    Kesecioglu J; Beale R; Stewart TE; Findlay GP; Rouby JJ; Holzapfel L; Bruins P; Steenken EJ; Jeppesen OK; Lachmann B
    Am J Respir Crit Care Med; 2009 Nov; 180(10):989-94. PubMed ID: 19713451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is surfactant a promising additive drug in ALI/ARDS-patients?
    Schultz MJ; Kesecioglu J
    Curr Drug Targets; 2004 Jul; 5(5):445-8. PubMed ID: 15216910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric calfactant in acute respiratory distress syndrome trial.
    Willson DF; Thomas NJ; Tamburro R; Truemper E; Truwit J; Conaway M; Traul C; Egan EE;
    Pediatr Crit Care Med; 2013 Sep; 14(7):657-65. PubMed ID: 23846250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous surfactant may improve oxygenation but not mortality in adult patients with acute lung injury/acute respiratory distress syndrome: a meta-analysis of 9 clinical trials.
    Meng H; Sun Y; Lu J; Fu S; Meng Z; Scott M; Li Q
    J Cardiothorac Vasc Anesth; 2012 Oct; 26(5):849-56. PubMed ID: 22265270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial.
    Willson DF; Thomas NJ; Markovitz BP; Bauman LA; DiCarlo JV; Pon S; Jacobs BR; Jefferson LS; Conaway MR; Egan EA;
    JAMA; 2005 Jan; 293(4):470-6. PubMed ID: 15671432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous surfactant therapy for ARDS.
    Maruscak A; Lewis JF
    Expert Opin Investig Drugs; 2006 Jan; 15(1):47-58. PubMed ID: 16370933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant replacement therapy.
    Spragg RG
    Clin Chest Med; 2000 Sep; 21(3):531-41, ix. PubMed ID: 11019725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous surfactant in paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome.
    Playfor SD; Nootigattu VK
    Curr Drug Saf; 2006 May; 1(2):159-68. PubMed ID: 18690927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of exogenous surfactant treatment in a murine model of two-hit lung injury.
    Zambelli V; Bellani G; Amigoni M; Grassi A; Scanziani M; Farina F; Latini R; Pesenti A
    Anesth Analg; 2015 Feb; 120(2):381-8. PubMed ID: 25502842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of exogenous surfactant in the treatment of acute lung injury.
    Lewis JF; Veldhuizen R
    Annu Rev Physiol; 2003; 65():613-42. PubMed ID: 12517997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].
    Lauer S; Fischer LG; Stubbe HD; Van Aken H; Westphal M
    Anaesthesist; 2006 Apr; 55(4):433-42. PubMed ID: 16440205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of exogenous surfactant in acute lung injury.
    Lewis JF; Brackenbury A
    Crit Care Med; 2003 Apr; 31(4 Suppl):S324-8. PubMed ID: 12682460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis.
    Davidson WJ; Dorscheid D; Spragg R; Schulzer M; Mak E; Ayas NT
    Crit Care; 2006; 10(2):R41. PubMed ID: 16542488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracheal acid or surfactant instillation raises alveolar surface tension.
    Nguyen TL; Perlman CE
    J Appl Physiol (1985); 2018 Nov; 125(5):1357-1367. PubMed ID: 29771610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant therapy for acute lung injury and acute respiratory distress syndrome.
    Raghavendran K; Willson D; Notter RH
    Crit Care Clin; 2011 Jul; 27(3):525-59. PubMed ID: 21742216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing efficacy of exogenous surfactant in acute lung injury.
    Lewis JF; Veldhuizen RA
    Biol Neonate; 1995; 67 Suppl 1():48-60. PubMed ID: 7647158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.